The Immunoglobulin G (IgG) Synthesis Index and Rate Test is a specialized diagnostic procedure designed to measure the rate and index of IgG synthesis within the body. IgG is the most abundant type of antibody found in blood circulation, playing a crucial role in the immune system's ability to fight off viruses, bacteria, and other pathogens. This test is particularly important in the diagnosis and monitoring of autoimmune disorders and certain neurological conditions, where abnormal levels of IgG synthesis can indicate disease activity or progression.
Performed at DNA Labs UAE, a leading facility known for its advanced diagnostic services, the test involves analyzing a sample of the patient's blood and, in some cases, cerebrospinal fluid (CSF) to assess the synthesis rate and index of IgG. By comparing IgG levels in the blood to those in the CSF, healthcare professionals can gain valuable insights into the immune response within the central nervous system, aiding in the diagnosis of conditions like multiple sclerosis (MS) and other autoimmune or infectious diseases of the nervous system.
The cost of the Immunoglobulin G Synthesis Index and Rate Test at DNA Labs UAE is 570 AED. Given the complexity and the detailed information it provides, this test is a critical tool in the clinical assessment and management of patients with suspected immune-related neurological conditions, ensuring that they receive accurate diagnoses and appropriate treatment plans.
The Parvovirus B19 Antibody IgM Test is a specific diagnostic tool designed to detect the presence of Immunoglobulin M (IgM) antibodies against the Parvovirus B19 in the bloodstream. This test is crucial for identifying recent or acute infections caused by Parvovirus B19, a virus responsible for causing conditions such as erythema infectiosum (fifth disease) in children and polyarthropathy syndrome in adults. The presence of IgM antibodies typically indicates a current or recent infection, as these antibodies are produced by the immune system shortly after the initial exposure to the virus.
Conducted at DNA Labs UAE, a leading facility in medical diagnostics, the test offers reliable and accurate results. The cost of the Parvovirus B19 Antibody IgM Test at DNA Labs UAE is 570 AED. This test is particularly important for pregnant women, individuals with weakened immune systems, and those with symptoms suggestive of a Parvovirus B19 infection. Early detection through this test can lead to prompt management and treatment, reducing the risk of complications associated with the infection.
The Mycobacterium Tuberculosis rRNA Detection TMA Test is a highly sensitive diagnostic tool used for the rapid detection of Mycobacterium tuberculosis, the bacterium responsible for tuberculosis (TB), directly from patient specimens. Utilizing the Transcription-Mediated Amplification (TMA) technology, this test amplifies ribosomal RNA (rRNA) specific to Mycobacterium tuberculosis, providing accurate results faster than conventional culture methods. This innovative approach significantly enhances TB diagnosis, enabling timely initiation of treatment and reducing the risk of disease transmission.
Conducted at DNA Labs UAE, a leading facility in medical diagnostics, the test is priced at 590 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by skilled professionals, ensuring high-quality testing services. The Mycobacterium Tuberculosis rRNA Detection TMA Test at DNA Labs UAE represents a critical tool in the fight against tuberculosis, offering a reliable, quick, and efficient method for identifying infections and facilitating effective public health responses.
The Placental Growth Factor (PlGF) Test is a vital diagnostic tool used in assessing the risk and monitoring of certain conditions during pregnancy, such as preeclampsia. PlGF is a protein associated with placental development, and abnormal levels can indicate potential complications with the pregnancy. This test measures the amount of PlGF in the blood, providing crucial information for the early detection and management of conditions that could affect both the mother and the fetus's health.
At DNA Labs UAE, the PlGF Test is offered at a cost of 590 AED. DNA Labs UAE is equipped with state-of-the-art facilities and experienced professionals to ensure accurate and reliable test results. This test is particularly recommended for pregnant women who are at risk of developing preeclampsia, as it can help in taking preventive measures or interventions at an early stage. By opting for this test, expectant mothers can take a proactive step towards ensuring a healthier pregnancy outcome.
The "SCA-1 Spinocerebellar Ataxia ATXN1 Gene Mutation Test" is a specialized genetic test offered by DNA Labs UAE, designed to identify mutations in the ATXN1 gene, which are linked to Spinocerebellar Ataxia Type 1 (SCA-1). SCA-1 is a rare, inherited neurological disorder characterized by progressive loss of coordination, difficulty walking, and speech problems, among other symptoms. This condition is caused by a specific genetic mutation in the ATXN1 gene, which affects the brain's cerebellum and spinal cord.
The test is crucial for individuals with a family history of SCA-1 or those exhibiting symptoms, as it can provide definitive diagnosis and help in managing the condition. Early detection through this genetic testing can also inform family planning decisions for those carrying the mutation. The procedure involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for the presence of the ATXN1 mutation.
At DNA Labs UAE, the cost of the SCA-1 Spinocerebellar Ataxia ATXN1 Gene Mutation Test is 590 AED. The test is conducted in a state-of-the-art laboratory by skilled professionals, ensuring accurate and reliable results. Individuals seeking this test can expect a thorough and confidential service, with support and guidance provided throughout the testing process.
The SCA-12 Spinocerebellar Ataxia PPP2R2B Gene Mutation Test is a specialized genetic test designed to identify mutations in the PPP2R2B gene, which are associated with Spinocerebellar Ataxia Type 12 (SCA-12). SCA-12 is a progressive, neurodegenerative disorder characterized by tremors, difficulty with movement coordination (ataxia), and other neurological symptoms. This condition is inherited in an autosomal dominant pattern, meaning that a mutation in just one copy of the gene in each cell is sufficient to cause the disorder.
The test is conducted by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. Utilizing advanced genetic sequencing technologies, the test accurately detects the presence of specific mutations in the PPP2R2B gene that are known to cause SCA-12. This information is crucial for affected individuals and their families for several reasons. It can confirm a diagnosis of SCA-12, inform treatment and management strategies, and provide valuable information for family planning and genetic counseling.
The cost of the SCA-12 Spinocerebellar Ataxia PPP2R2B Gene Mutation Test at DNA Labs UAE is 590 AED. Given the specialized nature of this test and its importance in the diagnosis and management of SCA-12, it represents a critical investment in the health and well-being of individuals showing symptoms of or at risk for this condition.
The SCA-2 Spinocerebellar Ataxia ATXN2 Gene Mutation Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the ATXN2 gene, which are responsible for Spinocerebellar Ataxia Type 2 (SCA-2). SCA-2 is a progressive, neurodegenerative disorder characterized by poor coordination of hands, speech, and eye movements, alongside other symptoms that worsen over time. Early detection through this genetic test can be crucial for managing the condition, enabling timely intervention and counseling for affected individuals and their families. The test is priced at 590 AED, making it accessible for those who suspect they may carry this mutation or have a family history of SCA-2, facilitating early and informed healthcare decisions.
The SCA-3 Spinocerebellar Ataxia ATXN3 Gene Mutation Test is a specialized genetic test designed to identify mutations in the ATXN3 gene, which are known to cause Spinocerebellar Ataxia Type 3 (SCA-3). SCA-3, also known as Machado-Joseph Disease, is a progressive neurodegenerative disorder characterized by a variety of symptoms including coordination and balance difficulties, spasticity, and eye movement abnormalities. The condition is inherited in an autosomal dominant manner, meaning that having a mutation in just one of the two copies of the ATXN3 gene is enough to cause the disorder.
This test is crucial for individuals with a family history of SCA-3 or those exhibiting symptoms suggestive of the condition, as it can provide a definitive diagnosis. Moreover, it can also be used for predictive testing in asymptomatic family members to determine their risk of developing the condition in the future.
The SCA-3 test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 590 AED, making it an accessible option for those seeking to understand their genetic health or risk of inheriting SCA-3. DNA Labs UAE employs state-of-the-art technology and highly qualified professionals to ensure accurate and reliable test results, providing individuals and families with the information needed to make informed health decisions.
The SCA-6 Spinocerebellar Ataxia CACNA1A Gene Mutation Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the CACNA1A gene, which are associated with Spinocerebellar Ataxia Type 6 (SCA-6). SCA-6 is a genetic neurological disorder characterized by progressive loss of coordination, gait abnormalities, and speech difficulties, among other symptoms. This condition is inherited in an autosomal dominant manner, meaning a mutation in just one of the two copies of the gene can cause the disorder.
The test is crucial for individuals with a family history of SCA-6 or those showing symptoms of the condition, as it helps in confirming the diagnosis, enabling early intervention and management of the disease. It involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any mutations in the CACNA1A gene.
DNA Labs UAE offers this test at a cost of 590 AED. By providing this service, DNA Labs UAE contributes significantly to the early detection and management of Spinocerebellar Ataxia Type 6, thereby improving the quality of life for affected individuals and their families.
The "SCA-7 Spinocerebellar Ataxia ATXN7 Gene Mutation Test" is a specialized genetic test designed to identify mutations in the ATXN7 gene, which are known to cause Spinocerebellar Ataxia Type 7 (SCA-7). SCA-7 is a rare, inherited neurological disorder characterized by progressive ataxia, or loss of coordination and balance, as well as visual impairments due to degeneration of the cerebellum and other parts of the brain. This test is crucial for individuals with a family history of the disorder or those exhibiting symptoms, as it can confirm a diagnosis, allowing for better management of the condition and genetic counseling.
The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the ATXN7 gene that are responsible for SCA-7. This genetic testing is an important step in understanding the risk of passing the condition to future generations and can aid in making informed decisions about family planning.
In the United Arab Emirates, this test is available at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The cost of the SCA-7 Spinocerebellar Ataxia ATXN7 Gene Mutation Test is 590 AED, making it accessible for individuals seeking genetic testing for this condition. By opting for this test at DNA Labs UAE, patients can expect reliable results, professional counseling, and comprehensive support throughout the testing process.
